Patents by Inventor Toshiyasu Sakane

Toshiyasu Sakane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10550153
    Abstract: To provide a peptide that selectively activates type 2 neuromedin U receptor and is chemically stable under physiological conditions. A peptide represented by Formula (1) described in the specification.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: February 4, 2020
    Assignees: TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES, NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER, KYOTO PHARMACEUTICAL UNIVERSITY
    Inventors: Yoshio Hayashi, Kentaro Takayama, Mikiya Miyazato, Kenji Kangawa, Kenji Mori, Akira Yamamoto, Toshiyasu Sakane
  • Publication number: 20190359652
    Abstract: To provide a peptide that selectively activates type 2 neuromedin U receptor and is chemically stable under physiological conditions. A peptide represented by Formula (1) described in the specification.
    Type: Application
    Filed: January 19, 2018
    Publication date: November 28, 2019
    Inventors: Yoshio HAYASHI, Kentaro TAKAYAMA, Mikiya MIYAZATO, Kenji KANGAWA, Kenji MORI, Akira YAMAMOTO, Toshiyasu SAKANE
  • Publication number: 20100266670
    Abstract: This invention is to provide a transdermal administration type pharmaceutical preparation which has better transdermal absorptivity, safety and practical application for treatment of bone calcium metabolic diseases, such as high calcium in blood which resulted from osteoporosis, osteitis deformans and malignant tumors.
    Type: Application
    Filed: December 9, 2008
    Publication date: October 21, 2010
    Inventors: Akira Yamamoto, Toshiyasu Sakane, Hidemasa Katsumi, Fumio Kamiyama, Ying-shu Quan